We are live on ! Find out more
DG

David Greenspan Slate Path Capital

AUM $7.22B
1-Year Est. Return 110.75%
 

David Greenspan is the founder of Slate Path Capital, a long/short equity firm with roots in the Tiger Management network. The firm conducts fundamental research across sectors with an emphasis on differentiated views rather than index hugging. Greenspan’s filings attract attention among investors who follow Tiger Cub-style managers.

This Fund
S&P 500
This Quarter Est. Return
+26.61%
1 Year Est. Return
+110.75%
3 Year Est. Return
+393.62%
5 Year Est. Return
+449.87%
10 Year Est. Return
+5,767.79%
AUM
$1.86B
AUM Growth
+$346M
Cap. Flow
+$9.81M
Cap. Flow %
0.53%
Top 10 Hldgs %
81.62%
Holding
33
New
4
Increased
6
Reduced
3
Closed
6

Sector Composition

Rank Sector Weight
1 Communication Services 39.37%
2 Materials 28.71%
3 Healthcare 20.5%
4 Industrials 7.2%
5 Energy 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
1
Snap
SNAP
$8.86B
$237M 12.76%
14,505,000
+65,000
+0.5% +$957K
CHTR icon
2
Charter Communications
CHTR
$17.9B
$185M 9.96%
381,000
-88,000
-19% -$40.5M
B
3
Barrick Mining
B
$78.3B
$182M 9.81%
9,795,000
BHC icon
4
Bausch Health
BHC
$2.41B
$167M 8.99%
+5,579,948
New +$145M
NYT icon
5
New York Times
NYT
$10.6B
$159M 8.54%
4,930,000
-155,000
-3% -$4.81M
Z icon
6
Zillow
Z
$8.07B
$134M 7.24%
2,925,000
KEX icon
7
Kirby Corp
KEX
$7.39B
$134M 7.2%
1,493,000
+128,000
+9% +$10.6M
MOS icon
8
The Mosaic Company
MOS
$7.76B
$132M 7.13%
6,120,000
+1,890,000
+45% +$37.5M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$31.6B
$93.9M 5.06%
815,000
+200,000
+33% +$19.9M
FCX icon
10
Freeport-McMoran
FCX
$110B
$91.6M 4.93%
6,980,000
+6,795,000
+3,673% +$74.6M
PAAS icon
11
Pan American Silver
PAAS
$22B
$85.3M 4.59%
3,600,000
MDCO
12
DELISTED
Medicines Co
MDCO
$69.5M 3.74%
818,042
-2,876,958
-78% -$192M
EQT icon
13
EQT Corp
EQT
$33.6B
$54.2M 2.92%
+4,970,000
New +$48.6M
SBSW icon
14
Sibanye-Stillwater
SBSW
$8.9B
$39.1M 2.1%
3,935,000
+1,438,747
+58% +$11.1M
RETA
15
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$24.5M 1.32%
120,000
EEM icon
16
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.7B
$14.9M 0.8%
333,000
CUE icon
17
Cue Biopharma
CUE
$174M
$14.1M 0.76%
29,667
QURE icon
18
uniQure
QURE
$3.36B
$10M 0.54%
+140,000
New +$7.69M
ZG icon
19
Zillow
ZG
$8.27B
$8.46M 0.46%
185,000
I
20
DELISTED
INTELSAT S. A.
I
$7.73M 0.42%
1,100,000
LX
21
LexinFintech Holdings
LX
$219M
$3.13M 0.17%
225,000
TDW icon
22
Tidewater
TDW
$4.74B
$2.12M 0.11%
110,000
APRN
23
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$2.11M 0.11%
26,667
AG icon
24
First Majestic Silver
AG
$10.4B
$2.08M 0.11%
170,000
SNAP icon
25
CALL
Snap
SNAP
$8.86B
$1.8M 0.1%
110,000

Similar funds

David Greenspan's Q4 2019 Portfolio in Review

As of Q4 2019, David Greenspan held 33 positions worth $1.86B, up 23% from $1.51B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

David Greenspan's Q4 2019 filing shows 4 new, 6 increased, 3 reduced and 6 closed positions. Its largest new stake was Bausch Health: 5,579,948 shares worth $167M. The largest sale was Medicines Co, an estimated $192M.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, down from 45% a quarter earlier, followed by Materials and Healthcare.

  • David Greenspan's largest Q4 2019 buy was Bausch Health: 5,579,948 shares worth $167M.
  • David Greenspan added most to Freeport-McMoran in Q4 2019, an estimated $74.6M increase.
  • David Greenspan's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $192M.
  • David Greenspan fully exited GE Aerospace in Q4 2019, selling an estimated $92.5M.
  • David Greenspan's ten largest holdings make up 82% of its $1.86B portfolio in Q4 2019.
  • David Greenspan opened 4 new positions and closed 6 in Q4 2019.
  • David Greenspan's portfolio value rose 23% quarter-over-quarter to $1.86B.

Based on Slate Path Capital's 13F filing for Q4 2019, filed 14 Feb 2020.